U.S. Markets closed

Draganfly Inc. (DFLYF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4250-0.0220 (-4.92%)
At close: 3:50PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4470
Open0.4600
BidN/A x N/A
AskN/A x N/A
Day's Range0.4109 - 0.4600
52 Week Range0.2579 - 1.4600
Volume184,890
Avg. Volume152,615
Market Cap32.758M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Draganfly to Provide Global Flight Services for Varigard™
    GlobeNewswire

    Draganfly to Provide Global Flight Services for Varigard™

    Los Angeles, CA. , Oct. 29, 2020 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and Unmanned Vehicle Systems (“UVS”) sectors, is pleased to announce that it will be the exclusive supplier using its patented drone technologies to deliver Varigard’s pathogen and virus surface sanitizer to arenas, stadiums and concert venues. Varigard™ is a patented bio-based organic sanitizer and is the only product that has been lab tested to sequester and kill COVID-19, STAPH, MRSA, E Coli, A. BAUMANNII (EBOLA,SARS and others) and PNEUMONIA for a minimum of 2+ hours. Varigard™ comes in a hand sanitizer gel, surface disinfectant or atomized version for spraying large venues. All 3 products carry the 2+ hour sequestration and kill efficacy.“We are excited to team up with Draganfly and allow large venues to start serving their customers with a COVID-19 lab proven sanitizer that not only lasts for 2+ hours, but contains no toxic chemicals.” said Mike Paolillo, Varigard’s managing partner. “It is critical that we deliver cost effective and safe products to help get our world back to normal. Our partnership with Draganfly will allow us to do just that!”. "The surface disinfecting market size is surging and expected to reach $1.5 billion by 2027, due in part to the requirement to disinfect large areas like stadiums. Varigard™ has already established a technical leadership position and we look forward to providing the most advanced drones and services to their customers,” said Cameron Chell, CEO of Draganfly.About Varigard™Varigard™, LLC is an Alabama based company focused on delivering safe and effective solutions using their patented organic polymers to reimagine products in the world today. They have several ground-breaking technologies that were formulated to sequester and kill dangerous pathogens for extended periods of time before they can enter the human body. Varigard™ is growing quickly in the US market while they are working on expansion into other countries in 2021. For more information on Varigard™, please visit us at www.varigard.com.About DraganflyDraganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge software and systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.For more information on Draganfly, please visit us at www.draganfly.com. For additional investor information, visit https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.otcmarkets.com/stock/DFLYF/overview or https://www.boerse-frankfurt.de/aktie/draganfly-inc.Media Contact Arian Hopkins email: media@draganfly.comCompany Contact Email: info@draganfly.comForward-Looking StatementsThis release contains certain “forward looking statements” and certain “forward-looking ‎‎‎‎‎information” as defined under applicable Canadian securities laws. Forward-looking statements ‎‎‎‎‎and information can generally be identified by the use of forward-looking terminology such as ‎‎‎‎‎‎“may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar ‎‎‎‎‎terminology. Forward-looking statements and information are based on forecasts of future ‎‎‎‎‎results, estimates of amounts not yet determinable and assumptions that, while believed by ‎‎‎‎‎management to be reasonable, are inherently subject to significant business, economic and ‎‎‎‎‎competitive uncertainties and contingencies. Forward-looking statements include, but are not ‎‎‎‎‎limited to, statements with respect the ‎successful integration of the Varigard‘s products onto drones, market size of the surface disinfecting market and the efficacy of Varigard products. Forward-‎‎‎looking statements ‎and information are subject to various known and unknown ‎risks and ‎‎‎uncertainties, many of ‎which are beyond the ability of the Company to control or ‎predict, that ‎‎‎may cause the ‎Company’s actual results, performance or achievements to be ‎materially different ‎‎‎from those ‎expressed or implied thereby, and are developed based on ‎assumptions about such ‎‎‎risks, ‎uncertainties and other factors set out here in, including but not ‎limited to: the potential ‎‎‎impact of ‎epidemics, pandemics or other public health crises, including ‎the current outbreak of ‎‎‎the novel ‎coronavirus known as COVID-19 on the Company’s business, ‎operations and financial ‎‎‎condition, ‎the successful integration of technology, the inherent risks ‎involved in the general ‎‎‎securities ‎markets; uncertainties relating to the availability and costs of ‎financing needed in the ‎‎‎future; the ‎inherent uncertainty of cost estimates and the potential for ‎unexpected costs and ‎‎‎expenses, ‎currency fluctuations; regulatory restrictions, liability, ‎competition, loss of key ‎‎‎employees and ‎other related risks and uncertainties disclosed under the ‎heading “Risk Factors“ ‎‎‎in the Company’s ‎most recent filings filed with securities regulators in ‎Canada on the SEDAR ‎‎‎website at ‎www.sedar.com. The Company undertakes no obligation to ‎update forward-looking ‎‎‎information ‎except as required by applicable law. Such forward-looking ‎information represents ‎‎‎‎managements’ best judgment based on information currently available. ‎No forward-looking ‎‎‎‎statement can be guaranteed and actual future results may vary materially. ‎Accordingly, readers ‎‎‎‎are advised not to place undue reliance on forward-looking statements or ‎information.‎

  • Draganfly to Host Shareholder Update Call Including Live Demo of its COVID-19 Focused Infectious Disease Screening Technology
    GlobeNewswire

    Draganfly to Host Shareholder Update Call Including Live Demo of its COVID-19 Focused Infectious Disease Screening Technology

    Los Angeles, CA, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and Unmanned Vehicle Systems (“UVS”) sectors, announced today that it will host a virtual-only shareholder update call on October 29th, 2020 at 2PM MST/4PM EST. The shareholder update call will be facilitated by Draganfly CEO, Cameron Chell who will provide an update on the state of the industry, Draganfly’s current projects, customers, recent sales and the future-state road map.Earlier this week we announced launch of the Draganfly Vital Intelligence API integration for telehealth applications. The API enables telehealth applications to access the Vital Intelligence technology which will enable such applications to measure heart rate, respiratory rate and SPO2.Dr. Jack Chow, Former US Ambassador and Assistant Director-General of the World Health Organization on Infectious Disease and current Draganfly board of advisor member will address the current Global Pandemic scenario and the important role of Draganfly.Dr. Javaan Chahl, Defense science and technology chair at the University of South Australia and Chief Scientist for Draganfly’s Vital Intelligence platform will provide a live demo of the Draganfly Vital Sign Assessment technology which provides a quick, non-invasive (contactless) and anonymous measurement of an elevated body temperature and, with voluntary consent, heart rate, respiratory rate and blood oxygenation all from a camera that takes seconds to capture.“I am excited to provide an overview Draganfly’s accomplishments and milestones. Draganfly has made great strides across multiple revenue streams and verticals in the past six months,” said Cameron Chell, Draganfly CEO. “I am also honoured to be joined by Dr. Jack Chow who will discuss the current global health environment and how Draganfly is positioned with its social distancing and health measuring platform. In addition, Dr. Javaan Chahl our Chief Scientist will provide a live demo of our Vital Intelligence platform.”Registration for the call can be done here.The Company will answer pre-submitted questions at the conclusion of prepared remarks. Investors are asked to submit their questions to investor.relations@draganfly.com.About DraganflyDraganfly Inc. (OTCQB: DFLYF; CSE: DFLY; FSE: 3U8) is the creator of quality, cutting-edge UVS and software that revolutionize the way people do business. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer within the commercial UAV, RPAS, and UVS space, serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.For more information on Draganfly, please visit us at www.draganfly.com. For additional investor information, visit https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.otcmarkets.com/stock/DFLYF/overview or https://www.boerse-frankfurt.de/aktie/draganfly-inc.Media Contact Arian Hopkins email: media@draganfly.comCompany Contact Phone: 1-306-955-9907 Email: info@draganfly.comForward-Looking StatementsThis release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the current outbreak of the novel coronavirus known as COVID-19 on the Company’s business, operations and financial condition, the successful integration of technology, the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.

  • Draganfly Announces the Vital Intelligence API for Telehealth Applications
    GlobeNewswire

    Draganfly Announces the Vital Intelligence API for Telehealth Applications

    Los Angeles, CA., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer is pleased to announce the launch of the Draganfly Vital Intelligence API integration for telehealth applications. The API enables telehealth applications to access the Vital Intelligence technology which will enable such applications to measure heart rate, respiratory rate and SPO2.The Vital Intelligence technology supports kiosks, entry systems, hand-held devices, drones, robots and other edge computing scenarios. With a deployment time of as little as a week, API subscribers will be able to rapidly transform their existing applications without significant retooling of their existing solutions.Draganfly’s Vital Intelligence Smart Thermal + Vital Assessment Station and Social Distancing Awareness technology provides a quick, non-invasive (contactless) and anonymous measurement of an elevated body temperature, heart rate, respiratory rate, all from a camera that takes seconds to capture. The platform does not register any personal data of the individual being screened.The new API integration addresses two major challenges for development teams: 1. The integrator does not need to work with thermal cameras, signal processing or screening processes. Draganfly’s system manages the entire process automatically.   2. The Web based API is accessible to all common operating systems and development environments.The Vital Intelligence API integration offers best in class workflows, security and reporting utilizing a pre-built interface that can be white-labelled and directly integrated into any technology stack.“The API captures our experience about how a system like this can be used. It was designed to allow third party software to gain access to the capabilities of our range of vital signs solutions,” said Professor Javaan Chahl, Defense Science and Technology Chair at the University of South Australia and Draganfly's Chief Scientist for the project. “This screening and monitoring technology can now be integrated rapidly in this dynamic environment”.“Our new API integration is a true innovation accelerator for the telehealth industry,” said Cameron Chell, CEO of Draganfly. “By enabling our technology via an API integration, telehealth organizations will be able to add an additional layer of testing to their own technology eliminating developer time and increasing product innovation. In addition, the time and cost savings will enable customers to quickly adopt our technology with their existing applications which will extend their ecosystem of customers.”About DraganflyDraganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge software and systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.For more information on Draganfly, please visit us at www.draganfly.com. For additional investor information, visit https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.otcmarkets.com/stock/DFLYF/overview or https://www.boerse-frankfurt.de/aktie/draganfly-inc.Media Contact Arian Hopkins email: media@draganfly.comCompany Contact Email: info@draganfly.comForward-Looking StatementsThis release contains certain “forward looking statements” and certain “forward-looking ‎‎‎‎information” as defined under applicable Canadian securities laws. Forward-looking statements ‎‎‎‎and information can generally be identified by the use of forward-looking terminology such as ‎‎‎‎‎“may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar ‎‎‎‎terminology. Forward-looking statements and information are based on forecasts of future ‎‎‎‎results, estimates of amounts not yet determinable and assumptions that, while believed by ‎‎‎‎management to be reasonable, are inherently subject to significant business, economic and ‎‎‎‎competitive uncertainties and contingencies. Forward-looking statements include, but are not ‎‎‎‎limited to, statements with respect the ‎successful integration of the Draganfly Vital Intelligence API. Forward-‎‎‎looking statements ‎and information are subject to various known and unknown risks and ‎‎‎uncertainties, many of ‎which are beyond the ability of the Company to control or predict, that ‎‎‎may cause the ‎Company’s actual results, performance or achievements to be materially different ‎‎‎from those ‎expressed or implied thereby, and are developed based on assumptions about such ‎‎‎risks, ‎uncertainties and other factors set out here in, including but not limited to: the potential ‎‎‎impact of ‎epidemics, pandemics or other public health crises, including the current outbreak of ‎‎‎the novel ‎coronavirus known as COVID-19 on the Company’s business, operations and financial ‎‎‎condition, ‎the successful integration of technology, the inherent risks involved in the general ‎‎‎securities ‎markets; uncertainties relating to the availability and costs of financing needed in the ‎‎‎future; the ‎inherent uncertainty of cost estimates and the potential for unexpected costs and ‎‎‎expenses, ‎currency fluctuations; regulatory restrictions, liability, competition, loss of key ‎‎‎employees and ‎other related risks and uncertainties disclosed under the heading “Risk Factors“ ‎‎‎in the Company’s ‎most recent filings filed with securities regulators in Canada on the SEDAR ‎‎‎website at ‎www.sedar.com. The Company undertakes no obligation to update forward-looking ‎‎‎information ‎except as required by applicable law. Such forward-looking information represents ‎‎‎‎managements’ best judgment based on information currently available. No forward-looking ‎‎‎‎statement can be guaranteed and actual future results may vary materially. Accordingly, readers ‎‎‎‎are advised not to place undue reliance on forward-looking statements or information.‎